Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia
University of Washington
University of Washington
Medical College of Wisconsin
Medical College of Wisconsin
Institut de Cancérologie de la Loire
Assistance Publique - Hôpitaux de Paris